A detailed history of Beacon Pointe Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 1,415,496 shares of PFE stock, worth $39.6 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
1,415,496
Previous 100 1415396.0%
Holding current value
$39.6 Million
Previous $2,000 1963900.0%
% of portfolio
0.44%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $10.3 Million - $11.8 Million
398,448 Added 39.18%
1,415,496 $39.3 Million
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $8.72 Million - $11.3 Million
-333,581 Reduced 24.7%
1,017,048 $29.3 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $27.7 Million - $32.4 Million
863,869 Added 177.47%
1,350,629 $44.8 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $632,930 - $732,286
17,523 Added 3.73%
486,760 $17.9 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $109,070 - $141,994
2,769 Added 0.59%
469,237 $19.1 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $1.12 Million - $1.47 Million
26,938 Added 6.13%
466,468 $23.9 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $815,073 - $995,000
18,626 Added 4.43%
439,530 $19.2 Million
Q2 2022

Aug 11, 2022

SELL
$46.53 - $55.17 $5.51 Million - $6.53 Million
-118,347 Reduced 21.95%
420,904 $22.1 Million
Q1 2022

May 17, 2022

BUY
$45.75 - $56.69 $12.4 Million - $15.3 Million
270,734 Added 100.83%
539,251 $27.9 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $177,138 - $262,578
-4,287 Reduced 1.57%
268,517 $15.9 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $3.38 Million - $4.34 Million
86,010 Added 46.05%
272,804 $11.7 Million
Q2 2021

Aug 17, 2021

BUY
$35.91 - $40.68 $3.46 Million - $3.92 Million
96,411 Added 106.67%
186,794 $7.32 Million
Q1 2021

May 18, 2021

SELL
$33.49 - $37.77 $101,441 - $114,405
-3,029 Reduced 3.24%
90,383 $3.27 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $596,134 - $758,036
17,811 Added 23.56%
93,412 $3.44 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $152,876 - $179,358
-4,815 Reduced 5.99%
75,601 $2.78 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $399,210 - $484,301
13,254 Added 19.73%
80,416 $2.63 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $1.09 Million - $1.56 Million
40,329 Added 150.3%
67,162 $2.2 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $133,819 - $151,868
4,065 Added 17.85%
26,833 $1.05 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $145,750 - $188,995
-4,486 Reduced 16.46%
22,768 $819,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $33,540 - $37,658
-907 Reduced 3.22%
27,254 $1.18 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $96,037 - $105,513
2,561 Added 10.0%
28,161 $1.2 Million
Q4 2018

Feb 01, 2019

BUY
$38.47 - $43.86 $984,832 - $1.12 Million
25,600 New
25,600 $1.12 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.